Also, treatment of primary human brain microvascular cells and astrocytes with IFN-β upregulated CD73 expression and inhibited transmigration of CD4+ T cells via an in vitro BBB model indicating that the increased expression of CD73 is protective in MS (Niemelä et al., 2008). The gene discussed is IFNB1; the disease is myeloid sarcoma.